Average Co-Inventor Count = 3.28
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (20 from 4,945 patents)
2. Sanofi-a Ventis Deutschland Gmbh (2 from 1,829 patents)
3. Roche Innovation Center Copenhagen A/s (1 from 46 patents)
4. F. Hoffmann-la Roche Ag (168 patents)
23 patents:
1. 12259380 - Oligonucleotides for inducing paternal UBE3A expression
2. 11852627 - Oligonucleotides for inducing paternal UBE3A expression
3. 11320421 - Oligonucleotides for inducing paternal UBE3A expression
4. 11312711 - Morpholine derivative
5. 10739332 - Oligonucleotides for inducing paternal UBE3A expression
6. 10718753 - Oligonucleotides for inducing paternal UBE3A expression
7. 10577332 - Tetrazole derivatives
8. 10556870 - Imidazole compounds as EAAT3 inhibitors
9. 10508107 - Morpholine derivative
10. 10494633 - Oligonucleotides for inducing paternal UBE3A expression
11. 10457644 - Pyrazol compounds as EAAT3 inhibitors
12. 10457663 - Pyrazol-pyridine derivatives
13. 10273217 - Triazole derivatives
14. 10155741 - Pyridine or pyrimidine derivatives
15. 10092546 - Imidazole derivatives